ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 157 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 3.13 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $18,705,000 | +9.4% | 1,183,835 | -12.1% | 0.68% | +1.2% |
| Q1 2018 | $17,095,000 | +3.2% | 1,346,049 | -7.0% | 0.67% | +1.7% |
| Q4 2017 | $16,567,000 | +6.4% | 1,446,865 | +13.9% | 0.66% | +1.5% |
| Q3 2017 | $15,564,000 | +44.2% | 1,270,555 | +34.8% | 0.65% | +37.8% |
| Q2 2017 | $10,794,000 | +24.2% | 942,709 | +125.5% | 0.47% | +18.3% |
| Q1 2017 | $8,694,000 | 0.0% | 417,963 | 0.0% | 0.40% | -3.9% |
| Q4 2016 | $8,694,000 | +45.1% | 417,963 | +74.2% | 0.41% | +23.2% |
| Q2 2016 | $5,990,000 | – | 239,889 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |